Stem cells in treatment of lower extremity ulcers.

Применение клеточных технологий в лечении трофических язв
Turlybek Tuganbekov 1, Manarbek Askarov 2, Nurlan Ashimov 3, Dana Saipiyeva 4
More Detail
1 Surgical Diseases Department, Astana Medical University
2 Centre of Cell Technologies and Transplantation, National Scientific Medical Centre
3 Docent of Surgical Diseases Department, Astana Medical University
4 Astana Medical University
J CLIN MED KAZ, Volume 4, Issue 30, pp. 14-20.
OPEN ACCESS 2986 Views 2339 Downloads
Download Full Text (PDF)

ABSTRACT

Therapy of lower extremity ulcers remains one of the biggest challenges in the contemporary surgical world. Failure to guarantee stable results with traditional techniques has forced to seek for alternative ways. Various clinical and experimental studies speak for effectiveness of stem cells transplantation in the treatment of leg ulcers and complicated wounds due to their multifactorial impact on regeneration aspects such as cell proliferation, extracellular matrix synthesis, growth factors release, neovascularisation and angiogenesis. Moreover, stem cells can differentiate into skin and vascular components themselves. Stimulation of angiogenesis appears to be a key aspect in the wounds regeneration where microcirculation is affected, therefore effect of stem cell therapy on this primary pathogenetic mechanism allows to consider stem cells in conjunction with the basic therapy of underlying condition an effective alternative for the traditional therapy. The article highlights etiology and pathogenesis of lower extremity ulcers, the main treatment techniques and their brief description. A separate attention is given to the types and characteristics of stem cells and growth factors as well as their effects on healing of low extremities ulcers. Advantages and limitations of stem cell therapy are also discussed.
Keywords: lower extremity ulcers, stem cells, growth factors
Трофикалық жараны емдеу жəне жараның ұзақ уақыт бойы жазылмауы заманауи хирургия саласының басты мəселесі болып отыр. Дəстүрлі терапияны (емді) қолданудағы тұрақты əсердің болмауынан емдеудің басқа амал -тəсілдерін іздеуге тура келеді. Түрлі клиникалық жəне ғылыми зерттеулердің нəтижесі трофикалық жаралардың жазылуындағы өзекті жасушалардың трансплантациялау əсерінің жасушалар профилерациясы, экстрацеллюлярлық матриксінің жинақталуы, өсу (даму) қабілетінің шектелуіне, неоваскуляризациялану мен ангиогенездену сияқты регенарция əрекеттеріне əкеліп соғады, сонымен қатар, өзекті жасушалар өздігімен тері жəне көк тамырлар жасушаларына саралануы (ауысуы) мүмкін. Ангиогенездің стимуляциясы (қоздыруы) жара жазылуының негізгі аспектісі ретінде танылады, яғни оның пайда болуы нəтижесінде микроциркуляцияның бұзылу əрекеті байқалады, оның салдарынан негізі патогенетикалық механизмге өзекті жасушалардың əсер етуі дəстүрлі емдеуге жаңа тиімді тəсіл болып танылатын эритроптық емдеумен қабысудың жасушалық терапиясын қарастыруға болады. Мақалада трофикалық жаралардың этиологиясы мен патогенезі суреттеліп, заманауи емдік жолдарының қысқаша шолу жолдары келтіріледі. Ерекше назарды өзекті жасушалардың түрі мен ерекшелігіне, өсу факторына аударуға болады, сонымен бірге трофикалық жаралар - ды емдеуде олардың тигізер əсері сөз етіледі. Жасушалық терапияның (емнің) шектеуі мен басымдығы талқыланады.
Keywords: трофикалық жаралар, өзекті жасушалар, өсу факторлары

CITATION

Tuganbekov T, Askarov M, Ashimov N, Saipiyeva D. Stem cells in treatment of lower extremity ulcers.. Journal of Clinical Medicine of Kazakhstan. 2013;4(30):14-20.

REFERENCES

  • Савельев В.С., Гологорский В.А., Кириенко А.И. и др. Флебология. Руководство для врачей. под ред. В. С. Савельева. / М., Медицина. – 2001. – 664 с
  • Стойко Ю.М., Шайдаков Е.В., Ермаков Н.А. Комплексное лечение хронической венозной недостаточности нижних конечностей в стадии трофических расстройств. Consilium medicum. Приложение.- 2001.-С. 28–31
  • Jamieson W.G, DeRose G., Harris K.A. Management of venous stasis ulcer: long–term follow–up. Can J Surg. 1990; 33: 22–223
  • В.С.Савельев, Кириенко А.И., Богачев В.Ю., Гриненко Т.Ф., Алекперова Т.В. Хирургическое лечение варикозной болезни вен нижних конечностей в амбулаторно–поликлинических условиях. Методические рекомендации под ред. В.С.Савельева.– М.: Издательство НЦ ССХ им. А.Н. Бакулева РАМН.-2001.-20 с.
  • Wagner F.W. A classification and treatment program for diabetic, neuropatic and dysvascular foot problems. / In The American Academy of Ortopaedic Surgeons instructional course lectures. – St. Louis. – Mosby Year Book. – 1979. – P. 143 – 165.
  • Flanagan M. Improving accuracy of wound measurement in clinical practice // Ostomy Wound Manage. 2003. Vol. 49 (10). Р. 28–40
  • Савельев В.С., Кириенко А.И., Богачев В.Ю. Венозные трофические язвы. Мифы и реальность. Флеболимфология. 2000.-№11.-С.5–10.
  • Q. L. Zhong, F. R. Liu, D. W. Liu, et al., “Expression of β-catenin and cyclin D1 in epidermal stem cells of diabetic rats,” Molecular Medicine Reports, vol. 4, no. 2, pp. 377–381, 2011.
  • M. L. Usui, J. N. Mansbridge, W. G. Carter, M. Fujita, and J. E. Olerud, “Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 7, pp. 687–696, 2008.
  • T. Desta, J. Li, T. Chino, and D. T. Graves, “Altered fibroblast proliferation and apoptosis in diabetic gingival wounds,” Journal of Dental Research, vol. 89, no. 6, pp. 609–614, 2010.
  • Boateng J.S., Matthews M., Stevens H., Eccleston G. (2008) Wound healing dressings and drug delivery systems: a review // J Pharmaceutical Sci. 2008. Vol. 97 (8). Р. 2892–2923.
  • D. M. Bermudez, B. J. Herdrich, J. Xu et al., “Impaired biomechanical properties of diabetic skin: implications in pathogenesis of diabetic wound complications,” American Journal of Pathology, vol. 178, no. 5, pp. 2215–2223, 2011.
  • J. Berlanga-Acosta, “Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment,” International Wound Journal, vol. 8, no. 6, pp. 612–620, 2011.
  • S. Y. Aghdam, S. A. Eming, S. Willenborg, et al., “Vascular endothelial insulin/IGF-1 signaling controls skin wound vascularization,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 197–202, 2012.
  • E. K. Tiaka, N. Papanas, A. C. Manolakis, et al., “Epidermal growth factor in the treatment of diabetic foot ulcers: an update,” Perspectives in Vascular Surgery and Endovascular Therapy, vol. 24, no. 1, pp. 37–44, 2012
  • M. Yang, Q. Li, L. Sheng, H. Li, et al., “Bone marrow-derived mesenchymal stem cells transplantation accelerates tissue expansion by promoting skin regeneration during expansion,” Annals of Surgery, vol. 253, no. 1, pp. 202– 209, 2011.
  • G. K. Kolluru, S. C. Bir, and C. G. Kevil, “Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing,” International Journal of Vascular Medicine, vol. 2012, Article ID 918267, 30 pages, 2012.
  • Z. J. Liu and O. C. Velazquez, “Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing,” Antioxidants and Redox Signaling, vol. 10, no. 11, pp. 1869–1882, 2008
  • S. Guo and L. A. DiPietro, “Factors affecting wound healing,” Journal of Dental Research, vol. 89, no. 3, pp. 219– 229, 2010
  • TenBrook J.A., Iafrati M.D., O’Donnell T.F., Wolf M.P., Hoffman S.N., Pauker S.G., Lau J., Wong J.B. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery // Journal of Vascular Surgery. 2004. Vol. 39. Р. 583–589
  • Cullum N., Nelson E.A., Fletcher A.W., Sheldon T.A. Compression for venous leg ulcers. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD000265. DOI: 10.1002/14651858.CD000265.
  • Boyce S.T., Goretsky M.J., Greenhalgh et al. Comparative assesment of cultured skin substituces and native skin autograft for treatment of full- thickness burns //Annals of surgery .-1995.- Vol.22.- №.2.- p.743-752.
  • Seidman C.E., Raffeto J.D.bFGF induced alterations in cellular markers of senescence in growth rescued fibroblasts from chronic venous ulcer and venous re fl ux patients// Ann.Vase.Surg- 2003.- Vol.l7.- №3. - P.239-244.
  • Hjerppe A., Hjerppe M. Treatment of cronical leg ulcus with a Humen fibroblast-derived dermal substitute: A Case Series off 114 Patiens //Wonds.- 2004.-Vol.l6.- №3.-P.97-104.
  • Седов В . М., Андреев Д . Ю., Смирнова Т. Д. Культивируемые фибробласты плода человека в комплексном лечении язв нижних конечностей.// Клеточные культуры /Информ .бюл.-2006.- №21.- С.44-54.
  • Лазаренко В . А., Андрюхина Е . Г. Клеточная трансплантация в терапии венозных трофических язв.// Материалы X международного хирургического конгресса. -Ростов н / Д, 2005.- С.298.
  • Griffin XL, Smith CM, Costa ML (2009). “The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review”. Injury 40 (2): 158–62. doi:10.1016/j.injury.2008.06.025. PMID 19084836
  • R. Eldor, I. Raz, A. B. Yehuda, and A. J. M. Boulton, “New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies,” Diabetic Medicine, vol. 21, no. 11, pp. 1161–1173, 2004.
  • N. B. Menke, K. R. Ward, T. M. Witten, D. G. Bonchev, and R. F. Diegelmann, “Impaired wound healing,” Clinics in Dermatology, vol. 25, no. 1, pp. 19–25, 2007.
  • M. Yang, Q. Li, L. Sheng, H. Li, et al., “Bone marrow-derived mesenchymal stem cells transplantation accelerates tissue expansion by promoting skin regeneration during expansion,” Annals of Surgery, vol. 253, no. 1, pp. 202– 209, 2011
  • A. M. Hocking and N. S. Gibran, “Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair,” Experimental Cell Research, vol. 316, no. 14, pp. 2213–2219, 2010.
  • T. Desta, J. Li, T. Chino, and D. T. Graves, “Altered fibroblast proliferation and apoptosis in diabetic gingival wounds,” Journal of Dental Research, vol. 89, no. 6, pp. 609–614, 2010.
  • L. Chen, E. E. Tredget, P. Y. G. Wu, Y. Wu, and Y. Wu, “Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing,” PLoS ONE, vol. 3, no. 4, article e1886, Article ID e1886, 2008
  • C. Peng, B. Chen, H. K. Kao, et al., “Lack of FGF-7 further delays cutaneous wound healing in diabetic mice,” Plastic and Reconstructive Surgery, vol. 128, no. 6, pp. 673e–684e, 2011
  • X. Deng, S. Szabo, L. Chen et al., “New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis,” Current Pharmaceutical Design, vol. 17, no. 16, pp. 1643–1651, 2011
  • M. J. Lee, J. Kim, K. I. Lee, J. M. Shin, J. I. Chae, and H. M. Chung, “Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells,” Cytotherapy, vol. 13, no. 2, pp. 165–178, 2011
  • O. Z. Lerman, R. D. Galiano, M. Armour, J. P. Levine, and G. C. Gurtner, “Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia,” American Journal of Pathology, vol. 162, no. 1, pp. 303–312, 2003
  • R. Ruiz-Salmeron, A. de la Cuesta-Diaz, M. Constantino-Bermejo, et al., “Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia,” Cell Transplantation, vol. 20, no. 10, pp. 1629–1639, 2011
  • I. Hartlapp, R. Abe, R. W. Saeed et al., “Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo,” FASEB Journal, vol. 15, no. 12, pp. 2215–2224, 2001
  • J. F. Wang, H. Jiao, T. L. Stewart, H. A. Shankowsky, P. G. Scott, and E. E. Tredget, “Fibrocytes from burn patients regulate the activities of fi broblasts,” Wound Repair and Regeneration, vol. 15, no. 1, pp. 113–121, 2007